Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06971276 · ClinicalTrials.gov registry record
Assessing the Utility of Plasma ctHPVDNA for Anal Cancer Screening
A clinical trial of Anal Dysplasia, sponsored by Massachusetts Eye and Ear Infirmary.
- Active
- Registry status
- 101
- Enrollment target
- 1
- Study location
NCT06971276 is a study of Anal Dysplasia that is active but no longer recruiting, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 101 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06971276, a study of Anal Dysplasia, is active but no longer recruiting, sponsored by Massachusetts Eye and Ear Infirmary.
- ACTIVE NOT RECRUITING
- Registry status
- 101 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is to test a liquid biopsy assay for screening and classifying anal dysplasia from blood.
Conditions Studied
Study Locations (1)
Massachusetts
- Department of Infectious Diseases, Mass General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2024-04-03 |
| Est. Completion | 2026-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06971276
The ClinicalTrials.gov registry entry for NCT06971276 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anal Dysplasia appearing as the primary indexed condition, and to 0 interventions.
NCT06971276 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06971276 about?
NCT06971276 is a clinical study titled "Assessing the Utility of Plasma ctHPVDNA for Anal Cancer Screening". The study is to test a liquid biopsy assay for screening and classifying anal dysplasia from blood.
What is the current status of trial NCT06971276?
This trial is currently active not recruiting. The enrollment target is 101 participants. The study started on 2024-04-03. Estimated completion is 2026-01-31.
What conditions does trial NCT06971276 study?
This clinical trial studies the following conditions: Anal Dysplasia.
Who is sponsoring clinical trial NCT06971276?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06971276 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anal Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.